NVision Expands Quantum Platform into South Korea

NVision Quantum Technologies is set to expand its POLARIS platform to South Korea in a €2.5 million Horizon Europe-funded project. Known as RESQ, the initiative will enhance quantum-enhanced MRI for brain metastases research at Yonsei University. This marks NVision's venture into Asia, linking European innovation with the burgeoning healthcare infrastructure in Asia.

The consortium, comprising NVision, Yonsei University, Ulm University, and Tesla Dynamic Coils, aims to develop advanced metabolic imaging solutions. With brain metastases affecting one in five cancer patients, the project seeks to provide deeper insights into tumor metabolism, potentially improving diagnosis and treatment.

Pushing the international presence further, POLARIS is already operational in key institutions such as the Memorial Sloan Kettering Cancer Center in the US and the University of Cambridge in the UK, supporting diverse medical research.